AIM
DPLO

Acrospire Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Acrospire Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,035
Closed -$30K – 1825
2017
Q2 		$30K Buy
+2,035
New +$33.9K 0.03% 1295
2017
Q1 		– Sell
-3,967
Closed -$50K – 2626
2016
Q4 		$50K Buy
3,967
+2,567
+183% +$47.8K 0.02% 1404
2016
Q3 		$39K Buy
+1,400
New +$47K 0.03% 1215

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's DPLO Position: Q3 2017 in Review

Acrospire Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 2,035 shares — an estimated $30K sold.

Acrospire Investment Management first reported a position in DPLO in Q3 2016 and held it in 3 quarters. The position peaked at $50K in Q4 2016. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Acrospire Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,035 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $30K.
  • Acrospire Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 3 quarters.
  • Acrospire Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $50K in Q4 2016.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.